Janssen Korea to take legal actions over Ultracet
Published: 2007-11-16 07:00:00
Updated: 2007-11-16 07:00:00
Janssen Korea has pledged to take legal action against the nullification trial of Ultracet, a painkiller for the relief of moderate to severe pain, which has been raised by several Korean drug makers including Hanmi Pharm, a senior official said on November 13.
The detailed legal action will b...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
